Clinical Trials

“Cancer patients treated on clinical trials lived substantially longer than those not treated on trial.” -Journal of ClinicalOncology, 2018 using 12 million patient registry data from National Cancer Database


0 +

Active Studies

0 +

Active Studies
Cancer Types


Cancer Types

Why join a clinical trial?

Clinical trials help advance research and treatment options for cancer patients. If you have an advanced cancer, a rare cancer, or a cancer that has not responded to standard treatment options, exploring a clinical trial may be your best option.

New clinical trials added on Nov 30, 2022

  • Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts

    NCT Number : NCT05625659

  • TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer

    NCT Number : NCT05625932

  • Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer

    NCT Number : NCT05624996

  • Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib

    NCT Number : NCT05625087

  • Differences in Scans Between Cancer and Injection

    NCT Number : NCT05625217

  • ExoLuminate Study for Early Detection of Pancreatic Cancer

    NCT Number : NCT05625529

  • A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors

    NCT Number : NCT05625412

  • A Study of Peri-Operative Tumor Treating Fields (NovoTTF-200T) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

    NCT Number : NCT05624918

  • Effects for Oral Mucositis Care During Chemoradiotherapy in Cancer Patients: Evaluation of the Bee Products

    NCT Number : NCT05625841

  • REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss

    NCT Number : NCT05625360

  • Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer

    NCT Number : NCT05626309

  • Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T-lymphocytes) for the Treatment of Primary Central Nervous System Lymphoma

    NCT Number : NCT05625594

  • The Role of FAM19A4 and Hsa-mir-124 Methylation in Predicting Prognosis of Untreated Cervical Intraepithelial Neoplasia 2 (CIN 2)

    NCT Number : NCT05624827

  • Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study

    NCT Number : NCT05626101

  • Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion

    NCT Number : NCT05625893

  • Fruquintinib Combined With Sintilimab as Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma

    NCT Number : NCT05625737

  • A Study to Characterize Access to Specialty Care Received by American Indians/Alaska Natives

    NCT Number : NCT05624788

  • Improved Endotracheal Intubation Procedure and Early Oral Intake.

    NCT Number : NCT05624463

  • A Study of Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)

    NCT Number : NCT05625919

  • Equitable Smoking Relapse Prevention

    NCT Number : NCT05625685

  • Premarking of Axillary Nodes Before Start of Neoadjuvant Chemotherapy Using Magnetic Approach

    NCT Number : NCT05625698

  • Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning

    NCT Number : NCT05624736

  • A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil

    NCT Number : NCT05626088

  • Effects of PF-07901801,Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma

    NCT Number : NCT05626322

  • A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)

    NCT Number : NCT05624554

  • The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection

    NCT Number : NCT05625373

  • Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC

    NCT Number : NCT05626569

  • A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma

    NCT Number : NCT05625399

  • Gamma Knife Radiosurgery for Treatment of Essential Tremor

    NCT Number : NCT02255929

  • A Registry to Evaluate the Performance of the BDX-XL2 Test

    NCT Number : NCT03766958

  • Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL

    NCT Number : NCT05626400

  • Tofatib Treatment for IgG4-related Disease

    NCT Number : NCT05625581

  • Non-invasive MRD Assessment in Multiple Myeloma

    NCT Number : NCT05625971

  • MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma

    NCT Number : NCT05626127

  • Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery

    NCT Number : NCT05624424

  • Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions

    NCT Number : NCT05625308

  • Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

    NCT Number : NCT05625633

  • OTL-200 in Patients With Late Juvenile Metachromatic Leukodystrophy (MLD)

    NCT Number : NCT04283227

  • Tailored Health Literacy Follow-up in Cancer

    NCT Number : NCT05627180

  • Conversion Therapy of Disitamab Vedotin Combined With Sintilimab and S-1 in HER2 Overexpression Gastric Cancer

    NCT Number : NCT05627414

  • FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer

    NCT Number : NCT05627635

  • Establishment of a Clinical Diagnostic Model GAMAD for Early-stage HCC Based on Circulating Tumor DNA Methylation

    NCT Number : NCT05626985

  • A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors

    NCT Number : NCT05627063

  • Peer Genetic Coaches for Enhancing Genetic Testing Awareness, Navigation, and Delivery Among African American Men With Metastatic Prostate Cancer, The EXPAND Network

    NCT Number : NCT05627219

  • Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment

    NCT Number : NCT05627245

  • A Phase 1 Study to Evaluate CHM-1101 CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma

    NCT Number : NCT05627323

  • QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management

    NCT Number : NCT05626764

  • Total Mesorectal Excision(TME) With Lateral Lymph Node Dissection Versus TME After Neoadjuvant Chemo-radiotherapy

    NCT Number : NCT03587480

  • Comparison of Patient Satisfaction in Post-operative Breast Surgery Patients Having Physical Clinic and Tele Clinic Follow up: A Randomized Controlled Trial

    NCT Number : NCT05627193

  • Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy

    NCT Number : NCT05627427

  • Palbociclib and Tazemetostat in Combination With CPX-351 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

    NCT Number : NCT05627232

  • Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma

    NCT Number : NCT05626829

  • Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA)

    NCT Number : NCT03589924

  • A Prospective Clinical Trial of Colostomy-replacement Combined With Bio-mesh Placement in the Prevention of SSIH

    NCT Number : NCT05627284

  • Applying Artificial Intelligence to Optimize Early-stage Hepatocellular Carcinoma Treatment Based on Multi-modal Image

    NCT Number : NCT05627297

  • Development and Validation of a Deep Learning System for Nasopharyngeal Carcinoma Using Endoscopic Images

    NCT Number : NCT05627310

  • Meaning Making While Your Child is in Intensive Care

    NCT Number : NCT05627531

  • A Study Comparing the Health Effects of Two Diets Following UK Dietary Guidance in People Living With Overweight or Obesity

    NCT Number : NCT05627570

  • Response Adapted Incorporation of Tislelizumab Into the Front-line Treatment of Older Patients With Hodgkin lYmphoma

    NCT Number : NCT05627115

  • A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)

    NCT Number : NCT04921969

  • 68Ga-P15-041 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Prostate Bone Metastasis

    NCT Number : NCT05627778

  • ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer

    NCT Number : NCT05629442


    NCT Number : NCT05628194

  • Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene

    NCT Number : NCT05630105

  • The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer

    NCT Number : NCT05628038

  • ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy

    NCT Number : NCT05630131

  • A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor

    NCT Number : NCT05628857

  • Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer

    NCT Number : NCT05628610

  • Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer

    NCT Number : NCT05628363

  • Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)

    NCT Number : NCT05629065

  • TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx) EVO

    NCT Number : NCT05628376

  • A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy

    NCT Number : NCT05629585

  • A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer

    NCT Number : NCT05628870

  • A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies

    NCT Number : NCT05629689

  • Telemedicine Improves Pain-related Disabilities in Following up Cancer Pain Outpatient

    NCT Number : NCT05628246

  • Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage

    NCT Number : NCT05627752

  • Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Osimertinib (TAGRISSO) (ROSY-T)

    NCT Number : NCT05629234

  • Prevalence and Risk Factors for Sleep and Pain Among Breast Cancer Survivors on Aromatase Inhibitors

    NCT Number : NCT05628077

  • A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer

    NCT Number : NCT05630183

  • Quantification of Anastomostic Blood Flow With Fluorescence Imaging in Low Anterior Resection for Rectal Cancer

    NCT Number : NCT05627934

  • The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation

    NCT Number : NCT05629260

  • SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease

    NCT Number : NCT05628233

  • Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer

    NCT Number : NCT03711890

  • First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

    NCT Number : NCT05627960

  • Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPG

    NCT Number : NCT05630209

  • Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors

    NCT Number : NCT05629546

  • Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma

    NCT Number : NCT05628883

  • Olaparib Maintenance Therapy in Metastatic Breast Cancer

    NCT Number : NCT05629429

  • A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer

    NCT Number : NCT05629949

  • ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids

    NCT Number : NCT05629702

  • Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia (AML) Following Initial Treatment

    NCT Number : NCT05628623

  • Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From Non-squamous NSCLC

    NCT Number : NCT04345146

  • In Vivo Depiction Of Bone Vascularization With UHR-CT CT And Deep Learning Algorithm Reconstruction: A Preliminary Study

    NCT Number : NCT05628792

  • Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT

    NCT Number : NCT05628922

  • Efficacy and Safety Evaluation of Vi-sealer

    NCT Number : NCT05629611

  • Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

    NCT Number : NCT05629494

  • Virtual Reality Intervention for Patients Undergoing BMT

    NCT Number : NCT05629676

  • A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL

    NCT Number : NCT05627856

  • MAÏA - MAintain the Level of Independence Through Alimentation

    NCT Number : NCT05628155

  • Study of Lymphatic Dysfunction in Primary and Secondary Lymphedema

    NCT Number : NCT05629026

  • Effects of Vaginal Oxytocin Gel on Vaginal Cytologic Parameters in Postmenopausal Woman

    NCT Number : NCT05627791

  • Personalized Diabetes Text Messaging (DB-TEXT) Combined With Peer Support Education in Patients With Type 2 Diabetes

    NCT Number : NCT05629117

  • Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells

    NCT Number : NCT05628545

  • Phone Enabled Implementation of Cessation Support (PHOENICS)

    NCT Number : NCT05628389

  • MASCT-I Combined With Apatinib and/or PD1 in the Treatment of Tissue Sarcoma

    NCT Number : NCT04074564

  • Comparison of Three Different Puncture Techniques in EBUS-TBNA

    NCT Number : NCT05628454

  • TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHL

    NCT Number : NCT05631912

  • Evaluation of the Impact of a Forward Viewing Scope at Time of ERCP

    NCT Number : NCT05627882

  • Effects of Curcumin on Inflammation and Oxidative Stress in Pediatric Patients on Regular Hemodialysis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

    NCT Number : NCT05627843

  • Efficacy of a Preoperative Anaemia Clinic in Patients Undergoing Elective Abdominal Surgery

    NCT Number : NCT05628896

  • Remote Assessment of Lung Disease and Impact on Physical and Mental Health

    NCT Number : NCT05630599

  • Intermittent Fasting Interventions on Brain Health in Women

    NCT Number : NCT05628727

  • Brain Self-regulation for Parkinson's

    NCT Number : NCT05627895

  • Highly Processed Foods and Vascular Health

    NCT Number : NCT05628350

  • Time Restricted Eating for the Treatment of PCOS

    NCT Number : NCT05629858

  • Effects of Fos Biomedical Device on Diabetes Risk Factors and Sleep Quality in Adults at Risk for Type 2 Diabetes

    NCT Number : NCT05628597

  • Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy

    NCT Number : NCT05630937

  • Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients

    NCT Number : NCT05629845

  • A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)

    NCT Number : NCT05036135

Want alerts of new clinical trials into your email inbox? Subscribe today

Find a Trial

Enter a few details below to get started and we'll help you match up with active clinical trials

Cancer Details

8301 Trials found

Cancer Details

Eligibility Criteria


OncoPower Clinical Trial Features

OncoPower Clinical Trial Features


Clinical Trial Matching

Fill out your profile and we’ll match you with clinical trial opportunities that are tailored to you


Eligiblity Verification

We work directly with the researchers on your behalf to cut through the pile of paperwork and streamline inclusion and exclusion criteria


Reimbursement Options

Our team will connect you with financial resources available to clinical trial participants


Trial Sponsor Coordination

OncoPower works with the sponsoring organization to make sure you don’t have to do things twice when being onboarded with a clinical trial

FAQs For Patients

Clinical trials for cancer often compare a new drug or treatment modality with the current standard of care. Depending on the trial, you may be able to stay on your current medication. In addition to that, some Clinical trials in cancer are observational and follow a large population over several years and try to understand how other factors impact disease progression and survivorship. These often allow you to continue your course of treatment with your current team and answer survey questions from the research team.

There are some clinical trials that provide compensation and/or reimbursement for expenses. One advantage of using OncoPower to identify and connect with the right clinical trial is that we do some of this legwork for you. Our team will help identify and connect you with financial benefits open to you (some through the study sponsor, some through outside non-profits).

Time spent will vary greatly depending on the clinical trial and treatment being studied. OncoPower will help you understand this as you will find this information out during the informed consent process.

You are able to leave a clinical trial at any time, for any reason.

Every clinical trial has unique and specific inclusion and exclusion criteria that help the researchers. If you don’t qualify for a trial you’re interested in but would like to learn about more trials, simply fill out your patient profile on OncoPower and indicate that you’re interested in Clinical Trials and we’ll help match you to suitable trials.

Create Your Free Account Today

Begin offering a comprehensive digital experience for your patients.